MA
AMED

Montag & Associates’s Amedisys AMED Stock Holding History

Montag & Associates’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,591
Closed -$2.86M – 825
2022
Q1 		$2.86M Buy
+16,591
New +$2.48M 0.15% 146
2018
Q2 		– Sell
-13,389
Closed -$808K – 278
2018
Q1 		$808K Buy
+13,389
New +$763K 0.08% 183

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Montag & Associates's AMED Position: Q2 2022 in Review

Montag & Associates sold out of Amedisys (AMED) in Q2 2022, closing a stake of 16,591 shares — an estimated $2.86M sold.

Montag & Associates first reported a position in AMED in Q1 2018 and held it in 2 quarters. The position peaked at $2.86M in Q1 2022. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Montag & Associates reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Montag & Associates sold 16,591 Amedisys shares in Q2 2022, an estimated $2.86M.
  • Montag & Associates first reported a position in Amedisys in Q1 2018 and held it in 2 quarters.
  • Montag & Associates's Amedisys position peaked at $2.86M in Q1 2022.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Montag & Associates's 13F filing for Q2 2022, filed 10 Aug 2022.